Single B or T-cell epitope-based DNA vaccine using modified vector induces specific immune response against hepadnavirus

Immunology Letters

Volumn 99, Issue 2, 2005, Pages 186-192

  Xu, Huan Bin ^a   Xu, Wei ^a   Chu, Yi Wei ^a   Wang, Ying ^a   Xiong, Sidong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b E Institute of Immunology   (China)

Author keywords

B cell epitope; DNA vaccine; Hepadnavirus; T cell epitope

Indexed keywords

B LYMPHOCYTE ANTIBODY; DNA VACCINE; EPITOPE; GROWTH HORMONE; HEPATITIS B VACCINE; PEPTIDE; PLASMID VECTOR; RECOMBINANT DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA MODIFICATION; DOT HYBRIDIZATION; DRUG EFFICACY; DRUG SYNTHESIS; DUCK; ENHANCER REGION; FEMALE; GENE SEQUENCE; GENETIC ENGINEERING; GENETIC TRANSFECTION; HEPADNAVIRUS; HEPATITIS B VIRUS; HUMAN CYTOMEGALOVIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; MOLECULAR COMPUTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STOP CODON; SUPERNATANT; T LYMPHOCYTE; VACCINATION; VACCINE PRODUCTION; VIRUS IMMUNITY;

ANIMALS; CELL LINE; CLONING, MOLECULAR; DUCKS; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; HEPADNAVIRIDAE INFECTIONS; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS, DUCK; MICE; MICE, INBRED C57BL; PLASMIDS; TRANSFECTION; VACCINATION; VACCINES, DNA;

EID: 22044439748     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.02.014     Document Type: Article

References (39)

1. S.I. Bazhan, P.A. Belavin, S.V. Seregin, N.K. Danilyuk, I.N. Babkina, and L.I. Karpenko Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens Vaccine 22 2004 1672 1682
2. M. Mancini-Bourgine, H. Fontaine, D. Scott-Algara, S. Pol, C. Brechot, and M.L. Michel Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers Hepatology 40 2004 874
3. K. Hinoda, K.Q. Xin, N. Jounai, Y. Kojima, Y. Tamura, and E. Okada Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice Vaccine 22 2004 3676 3690
4. B. Autran, G. Carcelain, B. Combadiere, and P. Debre Therapeutic vaccines for chronic infections Science 305 2004 205 208
5. R. Chakrabarti, Y.G. Chang, K. Song, and G.J. Prudi-home Plasmids encoding membrane-bound IL-4 or IL-12 strongly costimulate DNA vaccination against carcinoembryonic antigen (CEA) Vaccine 22 2004 1199 1205
6. J.A. Berzofsky, M. Terabe, S. Oh, I.M. Belyakov, J.D. Ahlers, and J.E. Janik Progress on new vaccine strategies for the immunotherapy and prevention of cancer J Clin Invest 113 2004 1515 1525
7. R.M. Conry, D.T. Curiel, T.V. Strong, S.E. Moore, K.O. Allen, and D.L. Barlow Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients Clin Cancer Res 8 2002 2782 2787
8. K. Song, Y. Chang, and G.J. Prudi-homme Regulation of T-helper-1 versus T-helper-2 activity and enhancement tumor immunity by combined DNA-based vaccination and non-viral cytokine gene transfer Gene Therap 7 2000 481 492
9. S. Gurunathan, D.M. Klinman, and R. Seder DNA vaccines: immunology, application, and optimization Annu Rev Immunol 18 2000 927 974
10. J.B. Ulmer, J.J. Donnelly, S.E. Parker, G.H. Rhodes, P.L. Felgner, and V.J. Dwarki Heterologous protection against influenza by injection of DNA encoding a viral protein Science 259 1993 1745 1749
11. M. Ye, C.S. Morello, and D.H. Spector Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization J Virol 78 2004 11233 11245
12. N. Dikopoulos, P. Riedl, R. Schirmbeck, and J. Reimann Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T-cell responses in the liver Hepatology 40 2004 300 309
13. C.C. Wilson, D. McKinney, M. Anders, S. MaWhinney, J. Forster, and C. Crimi Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1 J Immunol 171 2003 5611 5623
14. H.Y. Zhang, S.H. Sun, Y.J. Guo, F.J. Zhou, Z.H. Chen, and Y. Lin Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus Vaccine 21 2003 4704 4707
15. R.A. Subbramanian, M.J. Kuroda, W.A. Charini, D.H. Barouch, C. Costantino, and S. Santra Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeys J Virol 77 2003 10113 10118
16. F. Rodriguez, L.L. An, S. Harkins, J. Zhang, M. Yokoyama, and G. Widera DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination J Virol 72 1998 5174 5181
17. P.K. Loi, H.F. Mcgraw, and N.J. Tublitz Peptides detection in single cells using a dot immunoblot assay Peptides 18 1997 749 753
18. J.S. Tuttleman, J.C. Pugh, and J.W. Summers In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus J Virol 58 1986 17 25
19. J. Köck, and H.J. Schlicht Analysis of the earliest steps of hepadnavirus replication: genome repairs after infectious entry into hepatocytes does not depend on viral polymerase activity J Virol 67 1993 4867 4874
20. B.S. Chapman, R.M. Theyer, K.A. Vincent, and N.L. Haigwood Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous exression in mammalian Nucleic Acids Res 19 1991 3979 3986
21. S. Chassot, V. Lambert, A. Kay, C. Godinot, B. Roux, and C. Trepo Fine mapping of neutralizing epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides Virology 192 1993 217 223
22. S. Yuasa, R.C. Cheung, Q. Pham, W.S. Robinson, and P.L. Marion Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide Virology 181 1991 14 21
23. Y.M. Wen, Y.Y. Xu, W. Zhang, and Y.Z. Liu A synthetic peptide elicits antibody reactive with the native duck hepatitis B virus pre-S protein J Gen Virol. 71 1990 2467 2469
24. W. Zhang, C.D. Hu, Y.F. Lou, Z.L. Li, D. Qu, and Y.M. Wen Analysis of the polypeptide mapping of duck hepatitis B virus surface antigen Chin J Microbiol Immunol 3 1988 258 271
25. Y.M. Wen, Y.Y. Xu, W. Zhang, Y.F. Luo, and Y.Z. Liu Analysis of the antigenic determinants of duck hepatitis B virus pre-S antigen Chin J Virol 6 1990 145 150
26. Y.M. Wen, S.D. Xiong, and W. ZHang Solid matrix-antibody-antigen complex can clear viremia and antigenemia in persistent duck hepatitis B virus infection J Gen Virol 75 1994 335 359
27. Y. Sato, M. Roman, H. Tighe, D. Lee, M. Corr, and M.D. Nguyen Immunostimulatory DNA sequences necessary for effective intradermal gene immunization Science 273 1996 352 354
28. A.M. Krieg, A.K. Yi, S. Matson, T.J. Waldschmidt, G.A. Bishop, and R. Teasdale CpG motifs in bacterial DNA trigger direct B-cell activation Nature 374 1995 546 549
29. A.M. Krieg, A.K. Yi, S. Matson, T.J. Waldschmidt, G.A. Bishop, and R. Teasdale CpG motifs in bacterial DNA trigger direct B-cell activation Nature 374 1995 546 549
30. G.A. Viglianti, C.M. Lau, T.M. Hanley, B.A. Miko, M.J. Shlomchik, and A. Marshak-Rothstein Activation of autoreactive B-cells by CpG dsDNA Immunity 19 2003 837 847
31. G.B. Lipford, T. Sparwasser, M. Bauer, S. Zimmermann, E.S. Koch, and K. Heeg Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines Eur J Immunol 27 1997 3420 3426
32. S. Takeshita, F. Takeshita, D.E. Haddad, K.J. Ishii, and D.M. Klinman CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression cell Immunol 206 2000 101 106
33. T. Jakob, P.S. Walker, A.M. Krieg, M.C. Udey, and J.C. Vogel Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA J Immunol 161 1998 3042 3049
34. F.X. Hubert, C. Voisine, C. Louvet, M. Heslan, and R. Josien Rat plasmacytoid dendritic cells are an abundant subset of MHC class II+ CD4+CD11b-OX62- and type I IFN-producing cells that exhibit selective expression of Toll-like receptors 7 and 9 and strong responsiveness to CpG J Immunol 172 2004 7485 7494
35. M.B. Rosset, C. Ballerini, S. Gregoire, P. Metharom, C. Carnaud, and P. Aucouturier Breaking immune tolerance to the prion protein using prion protein peptides plus oligodeoxynucleotide-CpG in mice J Immunol 172 2004 5168 5174
36. H. Poeck, M. Wagner, J. Battiany, S. Rothenfusser, D. Wellisch, and V. Hornung Plasmacytoid dendritic cells, antigen, and CpG-C license human B-cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help Blood 103 2004 3058 3064
37. J. Vollmer, R.D. Weeratna, M. Jurk, U. Samulowitz, M.J. McCluskie, and P. Payette Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation Immunology 113 2004 212 223
38. G.B. Lipford, M. Bauer, C. Blank, R. Reiter, H. Wagner, and K. Heeg CpG-containing synthetic oligonucleotides promote B and cytotoxic T-cell responses to protein antigen: a new class of vaccine adjuvants Eur J Immunol 27 1997 2340 2344
39. E.A. Moseman, X. Liang, A.J. Dawson, A. Panoskaltsis-Mortari, A.M. Krieg, and Y.J. Liu Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T-cells J Immunol 173 2004 4433 4442